T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Duke Energy
DUK
$96.3B
| $742M | 0.11% |
9,274,261
+8,029,879
| +645% | +$649M |
|
202
APA Corp
APA
$14B
| $740M | 0.11% |
15,513,239
-1,572,628
| -9% | -$70.8M |
|
203
Franklin Resources
BEN
$17.1B
| $727M | 0.11% |
23,915,534
+5,580,203
| +30% | +$180M |
|
204
Neurocrine Biosciences
NBIX
$15.9B
| $724M | 0.11% |
5,887,484
-42,823
| -0.7% | -$4.86M |
|
205
Fidelity National Financial
FNF
$12.8B
| $720M | 0.11% |
19,032,475
-4,180,064
| -18% | -$159M |
|
|
BNY
206
Bank of New York Mellon
BNY
$111B
| $718M | 0.1% |
14,081,222
-11,958,218
| -46% | -$629M |
|
|
NEE.PRR
207
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $711M | 0.1% |
12,471,825
-111,142
| -0.9% | -$6.45M |
|
208
SL Green Realty
SLG
$4B
| $704M | 0.1% |
7,452,222
-1,091,745
| -13% | -$108M |
|
209
Vulcan Materials
VMC
$36.3B
| $700M | 0.1% |
6,295,953
-1,819,068
| -22% | -$211M |
|
210
Casey's General Stores
CASY
$31B
| $695M | 0.1% |
5,386,747
+5,315
| +0.1% | +$611K |
|
211
Bristol-Myers Squibb
BMY
$130B
| $694M | 0.1% |
11,174,615
+565,258
| +5% | +$33.5M |
|
212
Accenture
ACN
$110B
| $681M | 0.1% |
3,998,939
-93,406
| -2% | -$15.5M |
|
213
American Electric Power
AEP
$67.9B
| $673M | 0.1% |
9,498,359
+1,338,855
| +16% | +$95.3M |
|
|
ULTI
214
DELISTED
Ultimate Software Group Inc
ULTI
| $668M | 0.1% |
2,074,414
-959,345
| -32% | -$284M |
|
215
Royal Caribbean
RCL
$82.4B
| $663M | 0.1% |
5,101,667
-1,654,658
| -24% | -$194M |
|
216
Baidu
BIDU
$35.6B
| $663M | 0.1% |
2,898,554
+33,311
| +1% | +$7.83M |
|
217
Bank of America
BAC
$453B
| $661M | 0.1% |
22,440,260
-208,969
| -0.9% | -$6.36M |
|
218
Sarepta Therapeutics
SRPT
$1.94B
| $658M | 0.1% |
4,075,000
-420,963
| -9% | -$57.5M |
|
219
GSK
GSK
$101B
| $657M | 0.1% |
13,086,281
-255,185
| -2% | -$13M |
|
|
CLGX
220
DELISTED
Corelogic, Inc.
CLGX
| $656M | 0.1% |
13,275,723
+1,033,689
| +8% | +$52.7M |
|
221
BP
BP
$111B
| $649M | 0.09% |
14,751,393
+2,310,281
| +19% | +$96.6M |
|
222
DexCom
DXCM
$34.3B
| $644M | 0.09% |
18,005,156
-4,321,116
| -19% | -$134M |
|
223
Micron Technology
MU
$1.03T
| $644M | 0.09% |
14,232,693
+8,119,604
| +133% | +$410M |
|
224
Restaurant Brands International
QSR
$26.1B
| $640M | 0.09% |
10,798,396
+1,321,416
| +14% | +$80.4M |
|
225
Weyerhaeuser
WY
$17.8B
| $637M | 0.09% |
19,753,052
-2,111,037
| -10% | -$73.3M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.